|
|
|
|
|
Monday Morning Messages |
|
28th May 2024
|
|
|
|
|
|
|
|
|
|
Today is Blood Cancer Awareness day
|
|
|
|
|
|
Our Childhood Leukaemia Research Group, is dedicated to studying blood cancers and how they develop very early in life. Today, 28th May, is Blood Cancer Awareness Day and we have shared a little video on social media about their work. Click on the link below to watch it and share it. |
|
|
|
|
|
|
|
|
Professor Teresa Lambe OBE, elected a Fellow of the Academy of Medical Sciences |
|
|
Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences.
|
|
|
|
|
New research assesses the function of a major genetic cause of neurodevelopmental disorders
|
|
|
New research, published in The American Journal of Human Genetics, has defined the functional impacts of hundreds of variants in a gene that is a major cause of neurodevelopmental disorders.
|
|
|
|
|
|
|
|
|
Elections by Congregation |
|
|
Congregation is the sovereign body of the University. It consists of about 5,000 members, comprising academic staff, heads and other members of governing bodies of colleges and societies and senior research, computing, library and administrative staff.
There are elections by Congregation currently being contested and voting will close at 4pm on Thursday 6 June. Click on the link below for further information and to cast your vote should you wish. |
|
|
|
|
|
The Nuffield Department of Primary Care Health Sciences (NDPCHS) is seeking independent committee members to review the applications to use and access their primary care research datasets and for the re-use and re-analysis of existing Departmental Trials, Cohorts or other studies.
Applications to this voluntary role are invited from academics, researchers and health professionals working in primary care or related fields.
|
|
|
|
|
|
|
|
|
Medical and Life Sciences Translational Fund |
|
|
The Translational Research Office (TRO) is pleased to announce the return of Medical and Life Sciences Translational Fund (MLSTF) this summer, which will be launched at the Translational Research Symposium on Wednesday 10 July at the Blavatnik School of Government. At the event, full details of the MLSTF scheme will be revealed which includes the continuation of the “Emerging Translational Innovators (ETI)” route especially for early-career researchers, fireside chats on what a winning translational grant application should look like, the importance of milestones in translational grants, and the potential routes for continuing the development of your commercialisation pathway. This is an in-person event only and places are limited so register your interest asap, via the link below. |
|
|
|
|
|
|
|
|
Oxford Biomedical Research Centre and BRC Open Day |
|
|
30 May 2024 | Westgate Centre | 10am - 3.30pm
Step into the future of healthcare at this Open Day event where you can experience interactive stands showcasing the ground-breaking research that is driving change for NHS patients. Learn more about new diagnostics and revolutionary treatments, and discover how YOU can play a part in shaping the future of medicine by participating in our research.
The directors of the two BRCs: Professor Helen McShane and Professor John Geddes, will officially open the event.
|
|
|
|
|
|
|
|
|
Wearables in mega-scale biobanks - are there some learnings for rare disease research? |
|
|
10 June 2024 | Richard Doll Lecture Theatre | 11am
Professor Aiden Doherty, Wellcome Trust Senior Research Fellow and Professor of Biomedical Informatics at the University of Oxford, will discuss the story behind the collection of wrist-worn accelerometer data in over 150,000 research participants across the UK and China, while also describing efforts to collect complementary open human activity recognition validation datasets to further enhance these resources. |
|
|
|
|
|
|
|
|
Talking Spectrum: Navigating Neurodivergence |
|
|
2 July 2024 | Online only | 11am
Dr Cressida Ryan will talk to us about her own neurodivergent journey and what that has meant for her working life.
Three key takeaways for the seminar will be:
-
The overall basket of neurodivergent traits is broad and may including contradictory and conflicting traits. This session will enable you to consider and respond more effectively to an individual’s personal “cluster” of traits.
-
General inclusive practice can improve life for everyone, not just neurodivergent people; this session will put forward some simple ways to be more inclusive without the need for specific reasonable adjustments.
-
This session will address and unpack a number of standard misunderstandings and myths about neurodivergence, increasing your general knowledge of the conditions covered and the impact of popular misconceptions.
Everybody is welcome to join. Please register via the link below.
|
|
|
|
|
|
|
|
|
New Therapeutic Approaches in Translational Mental Health |
|
|
16 September 2024 | Maths Institute | All day
This in-person conference is hosted by the Oxford Health BRC and sponsored by the UK Mental Health Mission. The event aims to bring together industry, academic & clinical researchers, the regulator and government research funding organisations to discuss the current challenges facing therapeutic development. The overall objective is to forge collaborations that can increase capacity and capability through partnerships to deliver paradigm changes in translational mental health research. The event includes keynotes, lightning talks, roundtable discussion and industry led workshop sessions by Angelini Pharma, Big Health, Boehringer Ingelheim, Karuna Therapeutics and Reckitt Benckiser. |
|
|
|
|
|
|
Can you help these malaria trials?
|
|
|
|
|
Oxford Vaccine Group would like to invite you to take part in a study in a challenge study to find a vaccine against malaria. The total study participation time is 18 months. If you would like any further information regarding the study please contact info@ovg.ox.ac.uk, or call 01865 611400 |
|
|
|
|
|
Oxford Vaccine Group is looking for volunteers to help us understand how our immune systems respond to repeated infection with malaria. By taking part in this challenge study, you could help the research aimed at preventing hundreds of thousands of child deaths. If you are aged 18 to 45 years old, in good health and live in the Thames Valley, then you may be eligible to take part in the BIO-004 study. All participants will be reimbursed for their time, inconvenience and travel up to £9,100. |
|
|
|
|
|
|